Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission

NCT05230173 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT05230173
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05230173 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
Lead sponsor
Mayo Clinic
Phase
Not applicable
Overall status
Recruiting
Start date
October 5, 2022
Completion date
February 1, 2029
Enrollment
216 (estimated)
Sites
24

Conditions

As the registry lists them; a condition with its own page is linked.

crohn disease, ulcerative colitis